A new study in JCO Oncology Practice (JCO OP) highlights an effective effort to increase the use of evidence-based, state smoking cessation programs among patients with cancer and survivors who use tobacco.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
The American Society of Clinical Oncology (ASCO) released a statement applauding the Surgeon General for releasing its first report on smoking cessation in 30 years. The report provides the latest evidence-based information on the public health consequences of tobacco use and effective ways to help people quit smoking.
The Food and Drug Administration (FDA) recently issued a ban on flavored e-cigarette pods, except for those that are menthol and tobacco flavored. Despite pressure for a comprehensive ban from the anti-smoking community, the FDA rule, as written, will affect a relatively small portion of the vaping industry. It will only apply to cartridge-based products, leaving larger, tank-style vapes exempt from the ban. Single use and disposable vapes, which are becoming increasingly popular among children, are also exempt.